<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40898308</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>"SPHERE" multi-component novel psychosocial intervention for people with HIV: study protocol for a randomised controlled trial.</ArticleTitle><Pagination><StartPage>337</StartPage><MedlinePgn>337</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">337</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-025-08904-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antiretroviral therapy (ART) has transformed HIV into a manageable health condition with normal life expectancy. However, people with HIV continue to have poorer mental health compared to background populations, which may be linked to stigma, lack of social support, or socioeconomic challenges. Personalised care aims to improve the outcomes of people with long-term health conditions and the National Health Service (NHS) Long Term Plan looks to implement this (including access to health coaching and social prescribing). The SPHERE trial aims to assess whether a health and well-being coaching and social prescribing intervention improves patient-reported health and well-being among people living with HIV who have psychosocial needs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">SPHERE will be conducted across seven HIV outpatient clinics in England and is a pragmatic, two-arm, parallel group randomised controlled trial (RCT) embedding a routine assessment of psychosocial needs in HIV care. Eligibility criteria are people living with HIV aged 18 or older, available for the duration of study follow-up and scoring 16 or more on an assessment of psychosocial need: "Positive-Outcomes-11" (PO-11), covering physical, psychological, social and socioeconomic aspects of health and well-being. The RCT requires 568 participants who will be individually randomised in a 1:1 ratio to either a health and well-being coaching and social prescribing intervention or usual care. The intervention consists of up to eight coaching sessions that will be delivered by health professionals (e.g. HIV nurses) who have received specialist training to become health and well-being coaches. The trial will also include an internal pilot phase, process evaluation (to evaluate intervention feasibility, acceptability and mechanisms of action), economic evaluation (to assess the cost-effectiveness of the intervention and impact on NHS resource use) and parallel observational study (to assess subsequent development of psychosocial needs among those not initially eligible for the trial). The primary outcome is defined as achieving a reduction in PO-11 score of at least 40% from baseline to 6&#xa0;months post-randomisation. Secondary outcomes include symptoms of depression and anxiety, social support, self-stigma, coping self-efficacy, resilience, lifestyle factors and health-related quality of life.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The SPHERE trial will evaluate the effectiveness and cost-effectiveness of implementing psychosocial health and well-being coaching in a secondary HIV care setting. If effective, this model of personalised care could be transferable to other long-term health conditions.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">International Standard Randomised Controlled Trials Number (ISRCTN) Registry: ISRCTN47187932 [registered 12 July 2024].</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampe</LastName><ForeName>Fiona C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sewell</LastName><ForeName>Janey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Colette J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briggs</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Public Health and Policy, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottridge</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apea</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kings College Hospital NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lockyer</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asboe</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Chelsea and Westminster Hospital NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schembri</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Hathersage Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nixon</LastName><ForeName>Eileen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Sussex County Hospital, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Charlie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loi</LastName><ForeName>Shrushma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparrowhawk</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>George House Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolley</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheed</LastName><ForeName>Versha</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ives</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhir</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Living Well CIC, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherr</LastName><ForeName>Lorraine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal Free London NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Andrew N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harding</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Florence Nightingale Faculty of Nursing Midwifery and Palliative Care, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal Free London NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Public Health and Policy, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodger</LastName><ForeName>Alison J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-8817-4651</Identifier><AffiliationInfo><Affiliation>Institute for Global Health, University College London, London, UK. alison.rodger@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Royal Free London NHS Trust, London, UK. alison.rodger@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NIHR202038</GrantID><Agency>Programme Grants for Applied Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064792" MajorTopicYN="N">Pragmatic Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012944" MajorTopicYN="N">Social Support</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083626" MajorTopicYN="Y">Psychosocial Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057545" MajorTopicYN="N">Social Stigma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Economic evaluation</Keyword><Keyword MajorTopicYN="N">England</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">Health coaching</Keyword><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Process evaluation</Keyword><Keyword MajorTopicYN="N">Psychosocial intervention</Keyword><Keyword MajorTopicYN="N">Randomised controlled trial</Keyword><Keyword MajorTopicYN="N">Social prescribing</Keyword><Keyword MajorTopicYN="N">Stigma</Keyword><Keyword MajorTopicYN="N">Wellbeing</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The trial will be conducted in accordance with the UK Policy Framework for Health and Social Care Research and applicable UK Acts of Parliament and Statutory Instruments (and relevant subsequent amendments), and the principles of Good Clinical Practice as set out in the UK Statutory Instrument (2004/1031 and subsequent amendments). Ethical approval has been received from London &#x2013; Fulham Research Ethics Committee (ref: 24/LO/0449). All participants will provide informed consent throughout the trial by completing an online form (e-consent) or by paper. The Principal Investigator at each trial site is required to obtain necessary local approvals before any participants are enrolled to SPHERE. Consent for publication: Not applicable. The manuscript does not contain individual personal data from patients. Competing interests: The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>18</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40898308</ArticleId><ArticleId IdType="pmc">PMC12406414</ArticleId><ArticleId IdType="doi">10.1186/s13063-025-08904-9</ArticleId><ArticleId IdType="pii">10.1186/s13063-025-08904-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Trickey A, Zhang L, Sabin CA, Sterne JAC. Life expectancy of people with HIV on long-term antiretroviral therapy in Europe and North America: a cohort study. Lancet Healthy Longev. 2022;3:S2.</Citation></Reference><Reference><Citation>Kitt H, Shah A, Chau C et al. HIV testing, PrEP, new HIV diagnoses and care outcomes for people accessing HIV services: 2024 report. The annual official statistics data release (data to end of December 2023). October 2024; UK Health Security Agency, London. Available from: https://www.gov.uk/government/statistics/hiv-annual-data-tables/hiv-testing-prep-new-hiv-diagnosesand-care-outcomes-for-people-accessing-hiv-services-2024-report. [cited 13 Jun 2025 ]</Citation></Reference><Reference><Citation>Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS. 2019;33(9):1411&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6635049</ArticleId><ArticleId IdType="pubmed">30950883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, Dehnad A, Aryankhesal A, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019;9(4):404&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">31537580</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, et al. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV. 2014;1(1):e32-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">26423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampe F, Miners A, Kreif N, Miltz A, Phillips A, Sewell J. Comparison of depression and anxiety between HIV-positive and HIV-negative people. In: 22nd International AIDS conference. Amsterdam; 2018.</Citation></Reference><Reference><Citation>Aghaizu A, Martin V, Kelly C, Kitt H, Farah A, Latham V, et al. Positive Voices: The National Survey of People Living with HIV. Findings from 2022. Report summarising data from 2022 and measuring change since 2017. London; 2023 Dec.</Citation></Reference><Reference><Citation>Miltz AR, Lampe FC, Bacchus LJ, McCormack S, Dunn D, White E, et al. Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial. BMC Public Health. 2019;19(1):431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482482</ArticleId><ArticleId IdType="pubmed">31023281</ArticleId></ArticleIdList></Reference><Reference><Citation>Burch LS, Smith CJ, Anderson J, Sherr L, Rodger AJ, O&#x2019;Connell R, et al. Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. Lancet Public Health. 2016;1(1):e26-36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5341147</ArticleId><ArticleId IdType="pubmed">28299369</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review. Curr HIV/AIDS Rep. 2015;12(4):421&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643391</ArticleId><ArticleId IdType="pubmed">26412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, et al. Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study. Lancet HIV. 2014;1(1):e22-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">26423813</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones TPW, Lampe FC, Arenas-Pinto A, Smith C, McDonnell J, Haddow L, et al. Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses. HIV Med. 2022;23(3):209&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9293433</ArticleId><ArticleId IdType="pubmed">34634176</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooden TE, Gardner M, Wang J, Chandan JS, Beane A, Haniffa R, et al. The risk of mental illness in people living with HIV in the UK: a propensity score-matched cohort study. Lancet HIV. 2022;9(3):e172&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">35123667</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7): e011453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947735</ArticleId><ArticleId IdType="pubmed">27412106</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhard EAN, Smit C, van Dijk PR, Kuijper TM, Wermeling PR, Weel AE, et al. Health-related quality of life of people with HIV. AIDS. 2018;32(1):103&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">29112062</ArticleId></ArticleIdList></Reference><Reference><Citation>Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care. 2009;21(6):742&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">19806490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowther K, Selman L, Harding R, Higginson IJ. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): A systematic review. Int J Nurs Stud. 2014;51(8):1171&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">24602830</ArticleId></ArticleIdList></Reference><Reference><Citation>Logie CH, James Ll, Tharao W, Loutfy MR. HIV, Gender, Race, Sexual Orientation, and Sex Work: A Qualitative Study of Intersectional Stigma Experienced by HIV-Positive Women in Ontario, Canada. PLoS Med. 2011 Nov 22;8(11):e1001124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222645</ArticleId><ArticleId IdType="pubmed">22131907</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus B, Brook G, Awosusi F, Barker G, Boffito M, Das S, et al. BHIVA guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals 2016 (2019 interim update). British HIV Association. 2019;</Citation></Reference><Reference><Citation>Shah A, Mackay N, Ratna N, Chau C, Okumu-Camerra K, Kolawole T, et al. HIV testing, PrEP, new HIV diagnoses and care outcomes for people accessing HIV services: 2023 report. The annual official statistics data release (data to end of December 2022). UK Health Security Agency. London; 2023 Oct.</Citation></Reference><Reference><Citation>Miners A, Lampe FC, Cambiano V, Schwenk A, Rodger A, Sadique Z, et al. Estimating the hospital costs of care for people living with HIV in England using routinely collected data. HIV Med. 2023;24(11):1115&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">37641541</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners AH, Llewellyn CD, Cooper VL, Youssef E, Pollard AJ, Lagarde M, et al. A discrete choice experiment to assess people living with HIV&#x2019;s (PLWHIV&#x2019;s) preferences for GP or HIV clinic appointments. Sex Transm Infect. 2017;93(2):105&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339551</ArticleId><ArticleId IdType="pubmed">27535762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai T, Bruton J, Kall M, Ma R, Pufall E, Day S, et al. Experience of primary care for people with HIV: a mixed-method analysis. BJGP Open. 2019 Dec;3(4):bjgpopen19X101665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6995868</ArticleId><ArticleId IdType="pubmed">31822490</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS. NHS Long Term Plan. 2019. Available from: https://www.longtermplan.nhs.uk/. [cited 2024 Jul 18].</Citation></Reference><Reference><Citation>Ham C, Charles A, Wellings D. The King&#x2019;s Fund. 2018. Shared responsibility for health: the cultural change we need. Available from: https://www.kingsfund.org.uk/publications/shared-responsibility-health. [cited 2024 Jul 22].</Citation></Reference><Reference><Citation>The Personalised Care Institute. What is personalised care?. 2024. Available from: https://www.personalisedcareinstitute.org.uk/what-is-personalised-care-2/. [cited 2024 Jul 29].</Citation></Reference><Reference><Citation>Huffman MH. Health Coaching: A Fresh, New Approach to Improve Quality Outcomes and Compliance for Patients with Chronic Conditions. Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional. 2009;27(8):490&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19745624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivel&#xe4; K, Elo S, Kyng&#xe4;s H, K&#xe4;&#xe4;ri&#xe4;inen M. The effects of health coaching on adult patients with chronic diseases: A systematic review. Patient Educ Couns. 2014;97(2):147&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">25127667</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster C, Skelton C, Leibbrandt R, Hines S, Bonevski B. Models of social prescribing to address non-medical needs in adults: a scoping review. BMC Health Serv Res. 2023;23(1):642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10268538</ArticleId><ArticleId IdType="pubmed">37316920</ArticleId></ArticleIdList></Reference><Reference><Citation>Pescheny JV, Randhawa G, Pappas Y. The impact of social prescribing services on service users: a systematic review of the evidence. Eur J Public Health. 2020;30(4):664&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">31199436</ArticleId></ArticleIdList></Reference><Reference><Citation>Miltz AR, Sewell J, Nakagawa F, Rein SM, Sherr L, Rodger A, et al. Evidence from high&#x2010;income countries on the effectiveness of psychosocial interventions to improve mental health, wellbeing and quality of life for adults living with HIV: a systematic review and meta&#x2010;analysis. J Int AIDS Soc. 2025 Apr 26;28(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11946541</ArticleId><ArticleId IdType="pubmed">40141017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013 Jan 9;346(jan08 15):e7586&#x2013;e7586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelchen-Matthews A, Harding R, Smith C, Aghaizu A, Nakagawa F, Kelly C, et al. Positive Outcomes-11: a short version of the Positive Outcomes patient reported outcome measure to assess health and wellbeing among people living with HIV. In: 25th International AIDS Conference. Munich, Germany; 2024. Available from: https://programme.aids2024.org/Abstract/Abstract/?abstractid=9012. [cited 2024 Jul 29].</Citation></Reference><Reference><Citation>Papageorgiou V, Cullen L, Witzel TC, Sparrowhawk A, Coukan F, Sewell J, et al. An (un)restricted living: a qualitative exploration of the mental health and well-being of people living with HIV in England. Soc Sci Med. 2025 Apr;118109.</Citation><ArticleIdList><ArticleId IdType="pubmed">40306195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sewell J, Kall M, Aghaizu A, Miners A, Sparrowhawk A, Holder J, et al. Preferences for a psychosocial intervention based on health and wellbeing coaching, for people with HIV in a secondary care setting in England, Wales and Scotland: a discrete choice experiment. In: HIV Drug Therapy Glasgow. Glasgow; 2024.</Citation></Reference><Reference><Citation>Harding R, Jones CI, Bremner S, Bristowe K, West B, Siegert RJ, et al. Positive Outcomes: Validity, reliability and responsiveness of a novel person-centred outcome measure for people with HIV. HIV Med. 2022;23(6):673&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305143</ArticleId><ArticleId IdType="pubmed">35014143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a Brief Depression Severity Measure. J Gen Intern Med. 2001;16(9):606&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sewell J, Kelly C, Aghaizu A, Kitt H, Pelchen-Matthews A, Martin V, Farah A, Smith C, Brown A, Humphreys C, Sparrowhawk A, Delpech V, Rodger A, Lampe F, Kall M. Methodology for the Positive Voices 2022 Survey of People With HIV Accessing Care in England, Wales, and Scotland: Cross-Sectional Questionnaire Study. JMIR Res Protoc. 2025;14:e58531. 10.2196/58531. Erratum in: JMIR Res Protoc. 2025;14:e72512. 10.2196/72512. PMID: 39793018; PMCID: PMC11759904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11759904</ArticleId><ArticleId IdType="pubmed">39793018</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadhead WE, Gehlbach SH, de Gruy F V, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire: Measurement of Social Support in Family Medicine Patients. Med Care. 1988;26(7):709&#x2013;23. Available from: http://www.jstor.org/stable/3765493.</Citation><ArticleIdList><ArticleId IdType="pubmed">3393031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagnild GM. The resilience scale user&#x2019;s guide: For the US English version of the Resilience Scale and the 14-item Resilience Scale (RS-14). Resilience center; 2011.</Citation></Reference><Reference><Citation>Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K, for the Ambulatory Care Quality Improvement Project (ACQUIP). The AUDIT Alcohol Consumption Questions (AUDIT-C): An Effective Brief Screening Test for Problem Drinking. Arch Intern Med. 1998;158(16):1789&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">9738608</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Social Care. General practice physical activity questionnaire (GPPAQ). 2013. Available from: https://www.gov.uk/government/publications/general-practice-physical-activity-questionnaire-gppaq. [cited 2024 Jul 17].</Citation></Reference><Reference><Citation>Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S. A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol. 2006;11(3):421&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1602207</ArticleId><ArticleId IdType="pubmed">16870053</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecham J, Knapp M, Thornicroft G, Brewin C, Wing J. Measuring mental health needs. Costing psychiatric interventions. 1992;2:200&#x2013;24.</Citation></Reference><Reference><Citation>Rodger A. Psycho-social intervention for people with HIV. ISRCTN. 2024. Available from: 10.1186/ISRCTN47187932 . [cited&#xa0;17 Jul 2024].</Citation></Reference><Reference><Citation>NHS England. Service specification: adult specialised services for people living with HIV. 2024. Available from: https://www.england.nhs.uk/publication/adult-specialised-services-for-people-living-with-hiv/. [cited 2024 Sep 17].</Citation></Reference><Reference><Citation>Wenzel L, Robertson R, Wickens C. What is commissioning and how is it changing? The King's Fund. 2023. Available from: https://www.kingsfund.org.uk/insight-and-analysis/long-reads/whatcommissioning-and-how-it-changing. [cited&#xa0;4 Jun 2025].</Citation></Reference><Reference><Citation>Barrows HS. An overview of the uses of standardized patients for teaching and evaluating clinical skills. AAMC. Academic Medicine. 1993;68(6).</Citation><ArticleIdList><ArticleId IdType="pubmed">8507309</ArticleId></ArticleIdList></Reference><Reference><Citation>British HIV Association. Standards of Care for People Living with HIV 2018 [Internet]. London; 2018. Available from: https://www.bhiva.org/standards-of-care-2018. [cited 23 Sep 2024].</Citation></Reference><Reference><Citation>Sewell J, Speakman A, Phillips AN, Cambiano V, Lampe FC, Gilson R, et al. Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study). JMIR Res Protoc. 2016;5(2): e128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927873</ArticleId><ArticleId IdType="pubmed">27307218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan GM, Feinn R. Using Effect Size&#x2014;or Why the P Value Is Not Enough. J Grad Med Educ. 2012;4(3):279&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3444174</ArticleId><ArticleId IdType="pubmed">23997866</ArticleId></ArticleIdList></Reference><Reference><Citation>Speakman A, Rodger A, Phillips AN, Gilson R, Johnson M, Fisher M, et al. The &#x2018;Antiretrovirals, Sexual Transmission Risk and Attitudes&#x2019; (ASTRA) Study. Design, Methods and Participant Characteristics. PLoS One. 2013 Oct 15;8(10):e77230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3797119</ArticleId><ArticleId IdType="pubmed">24143214</ArticleId></ArticleIdList></Reference><Reference><Citation>Miltz AR, Rodger AJ, Sewell J, Speakman A, Phillips AN, Sherr L, et al. Clinically significant depressive symptoms and sexual behaviour among men who have sex with men. BJPsych Open. 2017;3(3):127&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5421094</ArticleId><ArticleId IdType="pubmed">28507772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sewell J, Speakman A, Phillips AN, Cambiano V, Lampe FC, Gilson R, et al. Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study). JMIR Res Protoc. 2016;5(2): e128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927873</ArticleId><ArticleId IdType="pubmed">27307218</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508772</ArticleId><ArticleId IdType="pubmed">10474547</ArticleId></ArticleIdList></Reference><Reference><Citation>May C, Finch T, Rapley T. Normalization Process Theory. In: Nilsen P, Birken SA, editors. Handbook on Implementation Science. Edward Elgar Publishing; 2020. p. 144&#x2013;67.</Citation></Reference><Reference><Citation>May C, Finch T. Implementing, Embedding, and Integrating Practices: An Outline of Normalization Process Theory. Sociology. 2009;43(3):535&#x2013;54.</Citation></Reference><Reference><Citation>May C, Albers B, Bracher M, Finch TL, Gilbert A, Girling M, et al. Evaluating implementation contexts, mechanisms, and outcomes: A normalization process theory coding manual for qualitative research and instrument development. 2021 Sep.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861599</ArticleId><ArticleId IdType="pubmed">35193611</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreier M. Qualitative content analysis in practice. London: SAGE; 2012.</Citation></Reference><Reference><Citation>Timmermans S, Tavory I. Data analysis in qualitative research: Theorizing with abductive analysis. Chicago: University of Chicago Press; 2022.</Citation></Reference><Reference><Citation>Miles M, Huberman A, Salda&#xf1;a J. Qualitative data analysis: a methods sourcebook. 4th ed. Thousand Oaks, Califorinia : SAGE; 2020.</Citation></Reference><Reference><Citation>Vaughan D. Analytic Ethnography. In: Hedstr&#xf6;m P, Bearman P, editors. Oxford Handbook of Analytical Sociology. Oxford: Oxford University Press; 2009.</Citation></Reference><Reference><Citation>Jones KC, Weatherly H, Birch S, Castelli A, Chalkley M, Dargan A, et al. Unit Costs of Health and Social Care 2022 Manual. Kent, UK: Personal Social Services Research Unit (University of Kent) &amp; Centre for ; 2023. Available from: https://kar.kent.ac.uk/100519/. [cited 2024 Jul 22].</Citation></Reference><Reference><Citation>NHS England. National Cost Collection for the NHS. Available from: https://www.england.nhs.uk/costing-in-the-nhs/national-cost-collection/. [cited 2024 Jul 22].</Citation></Reference><Reference><Citation>National Institute for Health and Care Research. Online SoECAT Guidance. 2022. Available from: https://www.nihr.ac.uk/documents/online-soecat-guidance/30396. [cited 2024 Jul 22].</Citation></Reference><Reference><Citation>Hern&#xe1;ndez-Alava M, Pudney S. Mapping between EQ-5D-3L and EQ-5D-5L: A survey experiment on the validity of multi-instrument data. Health Econ. 2022;31(6):923&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9303872</ArticleId><ArticleId IdType="pubmed">35229404</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">9285227</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenwick E, O&#x2019;Brien BJ, Briggs A. Cost-effectiveness acceptability curves &#x2013; facts, fallacies and frequently asked questions. Health Econ. 2004;13(5):405&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">15127421</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. OUP Oxford; 2006. (Handbooks in Health Economic Evaluation). Available from: https://books.google.co.uk/books?id=NuYRBAAAQBAJ</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>